PHILIP BATH philip.bath@nottingham.ac.uk
Stroke Association Professor of Stroke Medicine
Dietary nitrate supplementation for preventing and reducing the severity of winter infections, including COVID-19, in care homes (BEET-Winter)-a randomised placebo-controlled feasibility trial
Bath, Philip M; Skinner, Cameron J C; Bath, Charlotte S; Woodhouse, Lisa J; Areti, Anastasia; Korovesi, Kyriazopoulou; Long, Hongjiang; Havard, Diane; Coleman, Christopher M; England, Timothy J; Leyland, Valerie; Lim, Wei Shen; Montgomery, Alan A; Royal, Simon; Avery, Amanda; Webb, Andrew J; Gordon, Adam L
Authors
Cameron J C Skinner
Charlotte S Bath
Dr LISA WOODHOUSE L.Woodhouse@nottingham.ac.uk
Research Fellow
Anastasia Areti
Kyriazopoulou Korovesi
Hongjiang Long
Diane Havard
Christopher M Coleman
TIMOTHY ENGLAND Timothy.England@nottingham.ac.uk
Professor of Stroke Medicine
Valerie Leyland
Wei Shen Lim
ALAN MONTGOMERY ALAN.MONTGOMERY@NOTTINGHAM.AC.UK
Director Nottingham Clinical Trials Unit
Simon Royal
AMANDA AVERY amanda.avery@nottingham.ac.uk
Associate Professor
Andrew J Webb
Adam L Gordon
Abstract
Purpose
Infections cause considerable care home morbidity and mortality. Nitric oxide (NO) has broad-spectrum anti-viral, bacterial and yeast activity in vitro. We assessed the feasibility of supplementing dietary nitrate (NO substrate) intake in care home residents.
Methods
We performed a cluster-randomised placebo-controlled trial in UK residential and nursing care home residents and compared nitrate containing (400 mg) versus free (0 mg daily) beetroot juice given for 60 days. Outcomes comprised feasibility of recruitment, adherence, salivary and urinary nitrate, and ordinal infection/clinical events.
Results
Of 30 targeted care homes in late 2020, 16 expressed interest and only 6 participated. 49 residents were recruited (median 8 [interquartile range 7–12] per home), mean (standard deviation) age 82 (8) years, with proxy consent 41 (84%), advance directive for hospital non-admission 8 (16%) and ≥ 1 doses of COVID-19 vaccine 37 (82%). Background dietary nitrate was < 30% of acceptable daily intake. 34 (76%) residents received > 50% of juice. Residents randomised to nitrate vs placebo had higher urinary nitrate levels, median 50 [18–175] v 18 [10–50] mg/L, difference 25 [0–90]. Data paucity precluded clinical between-group comparisons; the outcome distribution was as follows: no infection 32 (67%), uncomplicated infection 0, infection requiring healthcare support 11 (23%), all-cause hospitalisation 5 (10%), all-cause mortality 0. Urinary tract infections were most common.
Conclusions
Recruiting UK care homes during the COVID-19 pandemic was partially successful. Supplemented dietary nitrate was tolerated and elevated urinary nitrate. Together, infections, hospitalisations and deaths occurred in 33% of residents over 60 days. A larger trial is now required.
Citation
Bath, P. M., Skinner, C. J. C., Bath, C. S., Woodhouse, L. J., Areti, A., Korovesi, K., …Gordon, A. L. (2022). Dietary nitrate supplementation for preventing and reducing the severity of winter infections, including COVID-19, in care homes (BEET-Winter)-a randomised placebo-controlled feasibility trial. European Geriatric Medicine, 13, 1343-1355. https://doi.org/10.1007/s41999-022-00714-5
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 31, 2022 |
Online Publication Date | Nov 16, 2022 |
Publication Date | 2022-12 |
Deposit Date | Oct 28, 2022 |
Publicly Available Date | Nov 17, 2023 |
Journal | European Geriatric Medicine |
Print ISSN | 1878-7649 |
Electronic ISSN | 1878-7657 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 13 |
Pages | 1343-1355 |
DOI | https://doi.org/10.1007/s41999-022-00714-5 |
Public URL | https://nottingham-repository.worktribe.com/output/12901003 |
Publisher URL | https://link.springer.com/article/10.1007/s41999-022-00714-5 |
Files
Dietary nitrate supplementation
(655 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Prediction of major bleeding with a S2TOP-BLEED score in acute ischaemic stroke or TIA patients: a sub-study of the TARDIS trial
(2018)
Presentation / Conference Contribution
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search